最新 納斯達克 新聞與觀點 | Yellow

Ethereum reached a significant milestone this month when the Securities and Exchange Commission approved options trading for several spot Ethereum exchange-traded funds, potentially bolstering the cryptocurrency's market position despite recent price declines. BlackRock's iShares Ethereum Trust beca

Nasdaq has submitted an application to the Securities and Exchange Commission seeking approval to list and trade shares of VanEck's proposed Avalanche Trust, a spot exchange-traded fund that would offer investors indirect exposure to the AVAX cryptocurrency token. The filing marks another expansion

A prominent American economist has identified a concerning relationship between NASDAQ performance and Bitcoin valuation, warning that the cryptocurrency could face a catastrophic collapse if current market trends continue. Peter Schiff, a well-known Bitcoin skeptic, detailed his analysis in a socia

BioNexus Gene Lab Corp. has become the first Nasdaq-listed company to adopt an Ethereum-focused treasury strategy. The biotech firm announced the move Tuesday. The company did not disclose the exact percentage allocated to Ethereum. The decision follows Ethereum's inclusion in the U.S. "Crypto Strat

HBAR jumped 20% during Wednesday's trading. The surge followed Nasdaq's filing of a 19b-4 form with the SEC. The document seeks approval to list and trade Grayscale's spot HBAR exchange-traded fund. Market data suggests the rally may be losing steam. Several technical indicators now point to increas